Comparison

GB-115 vs Normoftal

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

GB-115

Also: Ranquilon, N-phenylacetyl-L-prolylglycine ethyl ester

Clinical Trials

A dipeptide anxiolytic and nootropic that acts as a CCK-1 (cholecystokinin) receptor antagonist. Developed in Russia with completed Phase 3 trials for anxiety. Users report significant improvements in focus, attention, and ADHD-like symptoms.

CognitiveHuman Trials
Normoftal

Also: Eye Peptide Bioregulator, Retina Peptide

Clinical Trials

A synthesized Khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. Developed to normalize retinal function and support eye health. Clinical studies in Russia report improved visual function in 95% of patients with various retinal pathologies.

CognitiveHuman Trials

Key Comparison Insights

  • Both peptides belong to the Cognitive category, suggesting similar primary applications.

Detailed Comparison

AttributeGB-115Normoftal
CategoryCognitiveCognitive
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionGB-115 works by blocking central cholecystokinin-1 (CCK-1) receptors in the brain. CCK is involved in anxiety, panic responses, and cognitive modulation. By antagonizing these receptors, GB-115 reduces anxiety while improving attention, processing speed, and reaction time. It also modulates dopaminergic pathways involved in focus and motivation.Normoftal normalizes eye function by reducing peptide deficiency and restoring protein synthesis inside retinal cells. Contains peptide AKS-G (lysine, glutamic acid). May have neuroprotective effects on retinal neurons by modulating gene expression and protein synthesis, helping preserve the integrity and function of retinal nerve cells critical for transmitting visual information to the brain.
Common Dosing
6 mg daily (2 mg three times daily)
2-3 times daily (morning, afternoon, evening)
2 capsules 1-2x daily
1-2x daily, before meals
AdministrationOral tablets or sublingualOral capsules, before meals
Typical Duration21+ days in clinical trials, effects noted by day 730-day courses, repeat after 2-6 months
Best Time to TakeMorning and throughout the dayMorning and evening, before meals
Possible Side Effects
May vary by individual
  • Generally well-tolerated
  • Minimal sedation compared to benzodiazepines
  • Headache (rare)
  • Mild gastrointestinal discomfort
  • No reported dependency or withdrawal
  • +2 more
  • Well-tolerated with no reported side effects
  • No allergic reactions in clinical studies
  • Individual intolerance to components (rare)
  • Should not replace standard eye treatments
Research SummaryClinical studies in patients with Generalized Anxiety Disorder (GAD) showed GB-115 (6mg/day) significantly improved reaction time, attention, and processing speed within 7 days of treatment. A 21-day trial with 31 patients demonstrated anxiolytic effects comparable to benzodiazepines without sedation or dependency. Currently in Phase II/III trials (NCT05586789) for anxiety disorders. Anecdotal reports suggest benefits for ADHD symptoms, though direct ADHD trials are pending.From 1995 to 2010, at the St. Petersburg Institute of Bioregulation and Gerontology, 1500 patients with retinal pathology were treated: 40.3% with macular degeneration, 30.3% with diabetic retinopathy, 23.0% with retinitis pigmentosa. Improved visual functions were reported in 95% of patients. Research suggests it may aid treatment of glaucoma, diabetic retinopathy, and age-related macular degeneration.

Frequently Asked Questions: GB-115 vs Normoftal

What is the difference between GB-115 and Normoftal?

GB-115 is a cognitive peptide that a dipeptide anxiolytic and nootropic that acts as a cck-1 (cholecystokinin) receptor antagonist. developed in russia with completed phase 3 trials for anxiety. users report significant improvements in focus, attention, and adhd-like symptoms. Normoftal is a cognitive peptide that a synthesized khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. developed to normalize retinal function and support eye health. clinical studies in russia report improved visual function in 95% of patients with various retinal pathologies. The main differences lie in their mechanisms of action and clinical applications.

Which is better, GB-115 or Normoftal?

Neither is universally "better" - the choice depends on your specific goals. GB-115 is typically used for cognitive purposes, while Normoftal is used for cognitive. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can GB-115 and Normoftal be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using GB-115 and Normoftal together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of GB-115 and Normoftal is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.